-
Courses
Courses
Choosing a course is one of the most important decisions you'll ever make! View our courses and see what our students and lecturers have to say about the courses you are interested in at the links below.
-
University Life
University Life
Each year more than 4,000 choose University of Galway as their University of choice. Find out what life at University of Galway is all about here.
-
About University of Galway
About University of Galway
Since 1845, University of Galway has been sharing the highest quality teaching and research with Ireland and the world. Find out what makes our University so special – from our distinguished history to the latest news and campus developments.
-
Colleges & Schools
Colleges & Schools
University of Galway has earned international recognition as a research-led university with a commitment to top quality teaching across a range of key areas of expertise.
-
Research & Innovation
Research & Innovation
University of Galway’s vibrant research community take on some of the most pressing challenges of our times.
-
Business & Industry
Guiding Breakthrough Research at University of Galway
We explore and facilitate commercial opportunities for the research community at University of Galway, as well as facilitating industry partnership.
-
Alumni & Friends
Alumni & Friends
There are 128,000 University of Galway alumni worldwide. Stay connected to your alumni community! Join our social networks and update your details online.
-
Community Engagement
Community Engagement
At University of Galway, we believe that the best learning takes place when you apply what you learn in a real world context. That's why many of our courses include work placements or community projects.
October EU awards major research funding to tackle neurodegenerative disorders
EU awards major research funding to tackle neurodegenerative disorders
Wednesday, 2 October 2024
Dr Kasia Whysall, Associate Professor at the College of Medicine, Nursing and Health Sciences at University of Galway.
University of Galway to lead multi-institutional study in Europe, supported by Joint Programme Neurodegenerative Disease Research
A research project aimed at advancing the understanding and treatment of neurodegenerative disorders has received €1.1 million in funding support by the European Union through the Joint Programme on Neurodegenerative Disease Research (JPND).
The funding will spearhead a collaborative project, led by researchers at University of Galway, in partnership with institutions in Poland, Italy and Turkey.
Neurodegenerative disorders, including Alzheimer's, Parkinson's, and Huntington's diseases, present a significant challenge due to their debilitating nature. Marked by the gradual deterioration of nerve cells, these conditions severely impact a person’s quality of life and place a substantial burden on patients, families, and healthcare systems.
The research will be led by Dr Kasia Whysall with Dr Leo Quinlan, Principal Investigators and Associate Professors at the College of Medicine, Nursing and Health Sciences at University of Galway.
Dr Whysall said: “This research endeavours to seek to unravel the complex mechanisms underlying neurodegeneration, with a particular focus on Alzheimer’s Disease.
“Specific proteins which accumulate as a result of the disease have been studied, however their regulation poses challenges.
"This project aims to uncover valuable insights into the early pathological processes driving neurodegeneration.
"Our research suggests that early changes in the function of enzymes known as V-ATPase, and how this affects lysosomes – a type of recycling centre in the body that helps cells function properly, could be a key target for intervention to restore metabolic balance. We also found that damage to these cell parts might make neurons more vulnerable, supporting our investigation into treatment strategies that target gene regulation."
The research will be driven by the pressing need for early detection and effective interventions, and will employ cutting-edge technologies and collaborative partnerships to explore novel pathways for development of treatments for Alzheimer’s disease. Central to the research will be the exploration of emerging biomarkers, including micro RNAs (miRs) and extracellular vesicles associated with these disorders and which hold promise as non-invasive indicators of disease onset and progression.
Dr Quinlan said: “Our goal is not only to identify potential biomarkers for early diagnosis, but also to elucidate the underlying mechanisms of neurodegenerative diseases. By combining our research with innovative therapeutic strategies, we hope to make significant strides towards improving the lives of individuals affected by these devastating conditions.”
Professor Martin O’Donnell, Executive Dean for the College of Medicine, Nursing and Health Sciences at University of Galway, said: “In addition to its potential implications for future clinical practice, this project is an opportunity to transform the landscape of neurodegenerative research, offering new avenues for targeting interventions and personalised treatments. The research partnerships established as part of this research underscores the importance of global cooperation in addressing pressing health challenges.”
Ends
Keywords: Press.
Author: Marketing and Communications Office , NUI Galway
« Back
Related news
10 October 2024
Minister O’Donovan launches Institute for Health Discovery and Innovation
8 October 2024
Citizen Science calls on volunteers to record urban foxes
7 October 2024
UN study highlights links between child trafficking and grave violations against children during armed conflict
1 October 2024
Universities mark US-Ireland relations and peacebuilding
30 September 2024
Samhlú Salthill – shifting art installation reimagines urban spaces